NeuroQuant®
Fast, accurate, and proven automated brain image analysis.
Elevate your ability to quickly assess and closely monitor neurodegenerative brain diseases with a reliable automated tool. NeuroQuant® is CE marked and was the first US FDA 510(k) cleared medical software for fully automated quantitative analysis of brain MR images.
Easy to integrate with your existing PACS system, NeuroQuant provides volumetric measurements of brain structures and compares the volumes to normative reference data adjusted for age, sex, and intracranial volume.
VIDEO: Quantitative Imaging for Dementia, a multi-case review with Dr. Bash
This is the first in a series of case reviews using quantitative imaging in the assessment of various diseases. Dr. Bash, neuroradiologist at RadNet, uses NeuroQuant and other tools in her review of 7 patient cases.
VIDEO: NeuroQuant MS Quantitative Imaging Report for Multiple Sclerosis with Dr. Bash
Neuroradiologists Dr. Suzie Bash of Radnet reviews the new NeuroQuant MS quantitative imaging report and its use in the diagnosis and treatment of multiple sclerosis. Dr. Bash is a current user of NeuroQuant and has been using it in her clinical practice for over 15 years.
OnQ® Prostate
OnQ® Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer.
Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS scoring.
OnQ Prostate: Multi-case study review demonstrating improved prostate cancer detection
Dr. Schwazrtzberg uses OnQ Prostate to assess prostate cancer. He evaluates the case using T2, DWI, and ADC, then reviews an RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI increases conspicuity and how, in this case, it informs his designation of the PI-RADS number.
RSNA AI Theater Presentation
Dr. Bash uses NeuroQuant in the assessment of Alzheimer’s disease and reviews the features and benefits of LesionQuant and discusses the lesion detection threshold settings that enable each site to configure the minimum lesion size and the sensitivity within the infratentorial, leukocortical, periventricular, and white matter regions. She reviews lesion counts and volumetrics, as well as several overlay series that inform her diagnoses.
Dr. Schwazrtzberg uses OnQ Prostate to assess prostate cancer. He evaluates the case using T2, DWI, and ADC, then reviews an RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI increases conspicuity and how, in this case, it informs his designation of the PI-RADS number.
Contact Us
Would you prefer to add a date and time directly to a calendar? Click here to schedule a discovery meeting.
